Why the study?
What are the incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors?
Population
Patients discharged home after craniotomy for malignant supratentorial tumors in California (1995–2010)
Design
Cohort
Follow-up
30 days
Authors
Loading...
May inform targeted discharge planning after glioma craniotomy; leaves open validation of modifiable predictors in prospective studies.
What are the incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors?
The 30-day readmission rate for patients discharged home after craniotomy for malignant supratentorial tumors is 13.2%, with some readmissions potentially preventable through targeted discharge planning.
Marcus et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: